Results 1 to 10 of about 1,112,203 (353)

Does a combined intravenous-volatile anesthesia offer advantages compared to an intravenous or volatile anesthesia alone: a systematic review and meta-analysis

open access: yesBMC Anesthesiology, 2021
Background In anesthesia, additive drug interactions are used for reducing dose and dose-dependent side-effects. The combination of propofol with volatile anesthetics is rather unusual but might have advantages compared to the single use regarding PONV ...
Alexander Wolf   +3 more
doaj   +2 more sources

Comparison of general anesthesia and continuous intravenous sedation for electrochemotherapy of head and neck skin lesions

open access: yesFrontiers in Oncology, 2022
BackgroundElectrochemotherapy of cutaneous tumor nodules requires local or general anesthesia. For multiple and larger nodules, general anesthesia is recommended by standard operating procedures.
Janez Benedik   +10 more
doaj   +1 more source

Ciprofol: A Novel Alternative to Propofol in Clinical Intravenous Anesthesia?

open access: yesBioMed Research International, 2023
Ciprofol is a novel compound that was independently developed in China. According to the Chinese product instructions approved by the China National Medical Products Administration and the information of official website, indications for ciprofol include
Mingyu Lu   +3 more
semanticscholar   +1 more source

Comparison of Propofol or Isoflurane Anesthesia Maintenance, Combined with a Fentanyl–Lidocaine–Ketamine Constant-Rate Infusion in Goats Undergoing Abomasotomy

open access: yesAnimals, 2021
This study aimed to compare, first, the anesthetic and cardiopulmonary effects of propofol or isoflurane anesthetic maintenance in goats receiving a fentanyl–lidocaine–ketamine infusion undergoing abomasotomy and, secondly, to compare the quality of the ...
Perla I. Velázquez-Delgado   +5 more
doaj   +1 more source

Total versus inhaled intravenous anesthesia methods for prognosis of patients with lung, breast, or esophageal cancer: A cohort study

open access: yesFrontiers in Surgery, 2023
ObjectiveTo explore the influences of total intravenous anesthesia (TIVA) and inhaled-intravenous anesthesia on the prognosis of patients with lung, breast, or esophageal cancer.MethodsIn this retrospective cohort study, patients with lung, breast, or ...
Xiangming Che, Tianzuo Li
doaj   +1 more source

Comparison of bleeding complications after pediatric kidney biopsy between intravenous sedation and general anesthesia: a nationwide cohort study

open access: yesBMC Pediatrics, 2023
Background An increasing number of studies are evaluating the safety of intravenous sedation compared with that of general anesthesia; however, data on bleeding complications after pediatric percutaneous renal biopsy performed under intravenous sedation ...
Akira Okada   +16 more
doaj   +1 more source

Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery

open access: yesAnesthesiology, 2020
Background: Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies.
K. Makito   +3 more
semanticscholar   +1 more source

The safety profile and effectiveness of propofol‐remifentanil mixtures for total intravenous anesthesia in children

open access: yesPaediatric anaesthesia, 2020
Total intravenous anesthesia is used in less than 10% of operations in the UK. Many pediatric anesthetists in the UK and Ireland administer total intravenous anesthesia to children using a mixture of propofol and remifentanil in the same syringe.
O. Bagshaw   +4 more
semanticscholar   +1 more source

Intravenous tPA therapy does not worsen acute intracerebral hemorrhage in mice [PDF]

open access: yes, 2013
Tissue plasminogen activator (tPA) is the only FDA-approved treatment for reperfusing ischemic strokes. But widespread use of tPA is still limited by fears of inadvertently administering tPA in patients with intracerebral hemorrhage (ICH).
Arai, Ken   +13 more
core   +7 more sources

Home - About - Disclaimer - Privacy